Key Takeaways
- Shares of Conagra have plummeted over 50% in three years, resulting in its demotion to the S&P SmallCap 600 index.
- The company’s 10% dividend yield leads the S&P 500, but Wall Street views it as untenable with new leadership at the helm.
- Market watchers anticipate CEO John Brase will slash the payout during the July 15 Q4 earnings call to reset expectations.
- The food manufacturer shoulders $7.3 billion in debt obligations, consuming roughly $400 million yearly in interest expenses.
- Among 21 Wall Street analysts tracking CAG, only 2 recommend buying, with consensus targeting $13.87 per share.
Trading at approximately $14.08, Conagra Brands (CAG) stock has hemorrhaged more than half its value across the last three years. This dramatic decline has catapulted its dividend yield to 10% — claiming the top spot across the entire S&P 500. Yet for dividend-focused investors, this seemingly attractive yield may signal danger rather than opportunity.
The food conglomerate faces a significant blow as it exits the S&P 500 to join the S&P SmallCap 600 when June concludes. This index relegation marks a humbling moment for the corporation responsible for household names including Slim Jim, Reddi-wip, and Marie Callender’s.
Conagra installed John Brase as its new chief executive in April, recruiting him from J.M. Smucker to replace Sean Connolly and orchestrate a corporate revival.
Investment analysts are scrutinizing Brase’s initial strategic moves — with widespread consensus predicting dividend reduction as an early priority.
TD Securities analyst Robert Moskow recently sat down with Brase and reported that the board has authorized him “a clean slate to evaluate investment spending, broad portfolio change, and a potential dividend cut to stabilize the business.”
Moskow noted that market participants would prefer the reduction to occur during the July 15 Q4 earnings announcement rather than delaying the inevitable. He maintains a Hold rating with a $14 price objective.
The Financial Reality
Surface-level metrics suggest Conagra maintains adequate dividend coverage. Its payout ratio registers at 58%, remaining well below the concerning threshold of 80–90%. The organization produces approximately $840 million in annual free cash flow against dividend obligations of roughly $670 million.
However, these figures mask underlying vulnerabilities.
Conagra wrestles with $7.3 billion in outstanding debt — reduced from exceeding $8 billion twelve months prior, yet still draining nearly $400 million yearly through interest payments. This debt burden constrains capital available for brand development and innovation.
Wall Street forecasters project earnings will contract over 7% for the fiscal year concluding in May 2027. Such declining profitability creates headwinds for a company already operating with limited financial flexibility.
Deutsche Bank analyst Steve Powers maintains a Hold recommendation with a $12 target — implying downside of roughly 14% from present trading levels. He observed that investor discussions have evolved from questioning whether dividend reduction occurs to debating the magnitude of cuts.
Portfolio Pressures and Brand Headwinds
Conagra has pursued portfolio streamlining through asset sales. The company divested Chef Boyardee in June 2025 for $600 million, followed by unloading Van de Kamp’s and Mrs. Paul’s frozen seafood lines for $55 million. Management has highlighted high-protein frozen offerings, including edamame and its Marie Callender’s Chicken Parmigiana Bowl, as expansion opportunities.
Yet the brand obstacles extend beyond simple product mix. Morningstar analyst Kristoffer Inton noted in December that frozen foods — Conagra’s core segment — confronts headwinds from fresh food preferences and evolving consumption patterns, including rising adoption of GLP-1 weight-loss medications.
Numerous Conagra brands struggle to resonate with millennial and Gen Z demographics.
Among the 21 analysts monitoring CAG, merely 2 assign Buy ratings, while 14 recommend Hold and 5 advise Sell. The consensus price target sits at $13.87, suggesting minimal appreciation potential from current valuations.
The company reports Q4 results on July 15.


